TFR2 and Parkinson disease: Our most salient data demonstrate that deletion of TfR2 in catecholaminergic cells—and thus also in the dopamine neurons of the SNpc—mitigates neuropathology in oxidative stress and proteotoxic models of PD and reduces the age-related iron increase in the SNpc.